Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Healthy Volunteer
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2037
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cannabinoid Hyperemesis Syndrome
Interventions: Haloperidol; Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Kidney Failure
Interventions: Daily Peritoneal Dialysis, Days-off Peritoneal Dialysis; Procedure
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 10
States / cities: Torrance, California • Atlanta, Georgia • Evanston, Illinois + 6 more

Conditions: Loneliness, Grief
Interventions: Psilocybin, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 21 Years to 65 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Endophthalmitis
Interventions: Moxifloxacin, Placebo; Drug
Lead sponsor: Jason Ahee, M.D.; Industry
Eligibility: 40 Years and older
Enrollment: 60,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: St. George, Utah

Conditions: Diet Quality, Young Adult Health, Communication
Interventions: Lying about unhealthy foods being healthy, Engineering foods to be addictive, Targeting groups, Piggybacking on social causes, Covering up the evidence about the harms of unhealthy foods, Control; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 645 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Treatment Resistant Depression (TRD), Major Depressive Disorder (MDD)
Interventions: Spaced Transcranial Direct Current Stimulation (tDCS), Sham Spaced tDCS; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 70 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: San Diego, California

Conditions: Spasmodic Dysphonia, Laryngeal Dystonia, Voice Tremor
Interventions: sodium oxybate; Drug
Lead sponsor: Kristina Simonyan; Other
Eligibility: 21 Years to 80 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Substance Use Disorder (SUD), Drug Overdose, Criminal Behavior
Interventions: Core-interagency community engagement approach, Enhanced-Core plus community engagement specialist; Other
Lead sponsor: Texas Christian University; Other
Eligibility: 18 Years and older
Enrollment: 1,620 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Benign Prostatic Hyperplasia
Interventions: Tranexamic Acid (IV), Placebo; Drug
Lead sponsor: Kaiser Permanente; Other
Eligibility: 45 Years and older · Male only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Demyelinating Diseases, Demyelination; Corpus Callosum, Multiple Sclerosis Brain Lesion, Multiple Sclerosis Acute and Progressive, Clinically Isolated Syndrome, CNS Demyelinating
Interventions: Clemastine Fumarate, Placebo; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 55 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Depression, Cancer, Stage III Breast Cancer, Stage II Breast Cancer, Stage I Breast Cancer, Stage III Prostate Cancer, Stage II Prostate Cancer, Stage I Prostate Cancer, Stage III Colorectal Cancer, Stage II Colorectal Cancer, Stage I Colorectal Cancer
Interventions: MINDSET, Enhanced Usual Care (EUC); Behavioral
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: Not listed
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Anorexia Nervosa
Interventions: Donepezil; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Gastric Cancer
Interventions: Short course radiation therapy, Standard of care neoadjuvant chemotherapy; Radiation · Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 4
States / cities: Los Angeles, California • Tampa, Florida • Boston, Massachusetts + 1 more

Conditions: Pediatric Cancer, Malnutrition, Child, Caregiver Burden
Interventions: Medically Tailored Meals, Caregiver Coaching; Other · Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 5 Years to 21 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Malignant Head and Neck Neoplasm
Interventions: Supportive Care, Survey Administration, Interview; Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 89 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Acellular Dermal Matrix, Alveolar Mucosa
Interventions: Phase I dental implant placement with acellular dermis, Phase II dental implant uncovery with acellular dermis; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Opioid Use Disorder, Fentanyl
Interventions: Injectable buprenorphine, Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets); Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obstructive Sleep Apnea
Interventions: KPAP, APAP; Device
Lead sponsor: SleepRes Inc.; Industry
Eligibility: 20 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Murfreesboro, Tennessee

Conditions: Pain, Acute
Interventions: Equity Report Cards; Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: Up to 17 Years
Enrollment: 4,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: High Grade Serous Ovarian, Ovarian Adenocarcinoma, Ovarian Cancer, Serous Adenocarcinoma of Ovary, Ovarian Cancer (OvCa)
Interventions: Exercise, Usual Care; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Colorectal Neoplasms, Neoplasms, Intrahepatic Cholangiocarcinoma, Adrenocortical Carcinoma, Metastasis, Neoplasm
Interventions: Carfilzomib; Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Medical Complexity
Interventions: Structured Agenda-Setting Tool; Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 7 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Autism, Prematurity
Interventions: Eye-tracking device; Device
Lead sponsor: Indiana University; Other
Eligibility: 14 Months to 48 Months
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Search by objective public record fields.

Discovering Determinants of Food Intake by Application of Artificial Intelligence to Complex, High-Dimensional Data

Haloperidol For Outpatient Symptom Management in Patients Diagnosed With Cannabinoid Hyperemesis Syndrome in the Emergrency Department

Days-Off Versus Daily Initial Peritoneal Dialysis Prescription

The Effects of Psilocybin on Social Connectedness

Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Young Adult Food Messaging Experiment

Home-Based Randomized Trial of Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression

Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor

Justice Community Overdose Innovation Network II TCU Hub

Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation

Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair Therapy

Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET)

An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa

Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer

From Kitchen to Clinic

Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial

Assessment of Two Soft Tissue Augmentation Using Acellular Dermis Around Dental Implants

Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine Initiation

KPAP Adherence Crossover Study

Use of Equity Report Cards to Mitigate Disparities in Emergency Medical Services (EMS) Care for Injured Children

Identifying Mediators of Exercise-induced Tumor Microenvironment Remodeling to Enhance Primary Chemotherapy Response (IMPROVE-Ovarian)

Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy

ASKids! Inpatient Agenda-Setting Study for Hospitalized Children With Medical Complexity

Eye Tracking and Autism in Former Preterm Infants